Inturai Ventures Corp. completed the second and final tranche of its non-brokered private placement, issuing 151,427 Units at $0.15 each for gross proceeds of $22,714.05. Across the full Offering, the company issued 6,424,758 Units for aggregate gross proceeds of $963,713.70. Each Unit includes one common share and one warrant, with each warrant exercisable at $0.25 for 24 months from issuance. The warrants may expire early if the shares close at or above $0.35 for five consecutive trading days, subject to company notice and a 30-day exercise period after the related press release. The financing was conducted under Canada’s Listed Issuer Financing Exemption in all provinces except Quebec and other qualifying jurisdictions, including the United States. The company said the Units issued under that exemption are immediately free-trading under applicable Canadian securities laws. Inturai also paid $9,900 and issued 66,000 finder warrants in connection with the first tranche; those warrants are exercisable at $0.25 until August 28, 2028, while securities issued to finders remain restricted from resale until December 29, 2026. The company’s offering document is available through its SEDAR+ profile and website. Inturai develops artificial-intelligence technologies for healthcare, military, smart-home and industrial applications. The release also contains forward-looking statements concerning the intended use of proceeds and cautions that business, market, regulatory and other uncertainties could cause actual results to differ.